Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/7b/76/77/7b7677e6-2fb5-73b0-e86c-6b08d46594b5/mza_3770290653101313342.jpg/600x600bb.jpg
Unveiling HLH/MAS
Medthority
3 episodes
1 month ago
Show more...
Science
Education
RSS
All content for Unveiling HLH/MAS is the property of Medthority and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Show more...
Science
Education
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/7b/76/77/7b7677e6-2fb5-73b0-e86c-6b08d46594b5/mza_3770290653101313342.jpg/600x600bb.jpg
Diagnosing secondary HLH/MAS: Tools, trends, and challenges
Unveiling HLH/MAS
44 minutes
4 months ago
Diagnosing secondary HLH/MAS: Tools, trends, and challenges
Episode 2. Francesca Minoia, a key contributor to the 2016 MAS classification criteria, chats with Michael Jordan to reflect on the study’s impact, the significance of lab trends, and the evolving role of biomarkers in diagnosis. They discuss challenges in early recognition, particularly in patients receiving biologics or presenting with MAS as an initial symptom, and how diagnostic tools are reshaping clinical practice.
Unveiling HLH/MAS